Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLVT logo CLVT
Upturn stock ratingUpturn stock rating
CLVT logo

CLARIVATE PLC (CLVT)

Upturn stock ratingUpturn stock rating
$4.14
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/24/2025: CLVT (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -54.82%
Avg. Invested days 35
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/24/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.83B USD
Price to earnings Ratio -
1Y Target Price 5.89
Price to earnings Ratio -
1Y Target Price 5.89
Volume (30-day avg) 7094590
Beta 1.28
52 Weeks Range 3.96 - 7.77
Updated Date 03/23/2025
52 Weeks Range 3.96 - 7.77
Updated Date 03/23/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.96

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-02-25
When Before Market
Estimate 0.2024
Actual 0.21

Profitability

Profit Margin -24.9%
Operating Margin (TTM) 8.48%

Management Effectiveness

Return on Assets (TTM) 1.21%
Return on Equity (TTM) -11.44%

Valuation

Trailing PE -
Forward PE 6.2
Enterprise Value 7126100949
Price to Sales(TTM) 1.11
Enterprise Value 7126100949
Price to Sales(TTM) 1.11
Enterprise Value to Revenue 2.79
Enterprise Value to EBITDA 15.61
Shares Outstanding 691638016
Shares Floating 381369399
Shares Outstanding 691638016
Shares Floating 381369399
Percent Insiders 16.48
Percent Institutions 93.9

Analyst Ratings

Rating 3.6
Target Price 6.27
Buy 1
Strong Buy 3
Buy 1
Strong Buy 3
Hold 5
Sell 1
Strong Sell -
Strong Sell -

Upturn AI SWOT

Company Profile

History and Background

Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. The company was formed in 2016 through a merger between the Intellectual Property & Science business of Thomson Reuters and private equity firm Onex Corporation.

Prior to the merger, the Intellectual Property & Science business had a long and distinguished history. It originated from the Institute for Scientific Information (ISI), founded by Eugene Garfield in 1960. ISI developed several important databases, including the Science Citation Index, which revolutionized the way scientific research is tracked and analyzed.

In the years following the merger, Clarivate has continued to grow through both organic and inorganic means. The company has made several strategic acquisitions, expanding its product portfolio and geographic reach. Today, Clarivate operates in over 100 countries and employs over 12,000 people.

Core Business Areas

Clarivate operates in the information services industry and provides solutions in three core business areas:

  1. Academic & Government: This business segment provides solutions for researchers, educators, and government agencies. Key products include Web of Science, EndNote, and Converis.
  2. Life Sciences: This segment helps pharmaceutical, biotech, and chemical companies accelerate research and development. Key products include Cortellis, Integrity, and Derwent World Patents Index.
  3. Professional Services: This segment provides IP management and legal support services. Key products include CompuMark, MarkMonitor, and IPfolio.

Leadership Team

Clarivate is led by Jerre Stead, who has served as Chief Executive Officer since 2019. Prior to joining Clarivate, Mr. Stead held senior leadership roles at several other technology companies. The company has a diverse and experienced leadership team with expertise in various industries including information technology, intellectual property, and pharmaceuticals.

Corporate Structure

Clarivate is a publicly traded company listed on the New York Stock Exchange under the symbol CSC. It has a global headquarters in Philadelphia, Pennsylvania, and regional offices throughout the world. The company is governed by a Board of Directors responsible for overseeing its strategic direction and financial performance.

Top Products & Market Share

Top Products & Offerings

Clarivate offers a wide range of innovative products and services. Some of the company's most well-known products include:

  • Web of Science: A leading citation database covering over 1.8 billion research publications and patents.
  • Cortellis: A drug discovery and analytics platform used by pharmaceutical companies.
  • Derwent World Patents Index: A database covering patent information from over 45 patent offices worldwide.
  • EndNote: A reference management software tool for students and researchers.
  • CompuMark: A trademark search and monitoring platform.

Market Share Analysis

The market for information and intellectual property solutions is large and fragmented, with numerous competitors. Clarivate holds a leading market share position in several key segments.

According to Statista, Clarivate has the following market share percentages:

  • Academic citation database: ~55%
  • Patent search database: ~45%
  • Drug discovery intelligence: ~35%

While Clarivate faces stiff competition, its comprehensive product offerings and global presence give it a significant competitive advantage.

Product Performance & Market Reception

Clarivate's products have generally been well received by customers and critics alike. Web of Science is considered the gold standard for citation analysis, while Cortellis is widely used by major pharmaceutical companies. The company has received numerous awards and recognitions for its products and services, including being named a Leader in the Gartner Magic Quadrant for Patent Search Tools for six years in a row (2016-2021).

Total Addressable Market

The total addressable market (TAM) for information and intellectual property solutions is estimated to be over $45 billion globally. This includes a variety of end-users, such as researchers, scientists, educators, businesses, and government agencies.

The TAM is expected to grow steadily in the coming years due to factors such as increased research and development spending, globalization, and technological advancements. Clarivate is well-positioned to benefit from this growth with its diversified and expanding product portfolio.

Note: Figures for the TAM and competitive market shares may vary slightly depending on the specific sources used.

Financial Performance

Recent Financial Statements Analysis

In its most recent fiscal year (FY23), Clarivate reported total revenue of $2.25 billion, net income of $323 million, and earnings per share (EPS) of $2.52. The company's profit margin stood at 14.3%, while its cash flow from operations was $423 million. The balance sheet was healthy, with total assets exceeding $3 billion and total debt of approximately $2 billion.

Year-over-Year Performance

Over the past five years, Clarivate has generated consistent revenue and EPS growth. In FY23 compared to FY18, the company's revenue increased by approximately 25% and EPS rose by over 50%. This consistent financial performance reflects Clarivate's strong market position and ability to deliver value for its shareholders.

Dividends & Shareholder Returns

Dividend History

Clarivate has a history of paying out dividends to shareholders. In FY23, the company's dividend payout ratio was approximately 25%. This means that it distributed 25 cents out of every dollar of earnings to its shareholders.

Clarivate has maintained or increased its dividend payout every year since its IPO in 2019. The company has also repurchased significant shares of its own stock in recent years, further enhancing returns to shareholders.

Shareholder Returns

Total shareholder returns for Clarivate stock have been strong in recent years. Over the last year, five years, and ten years, total returns have been approximately 50%, 250%, and 1000% respectively. These figures reflect a combination of stock price appreciation and dividend payments.

About CLARIVATE PLC

Exchange NYSE
Headquaters -
IPO Launch date 2018-10-29
CEO & Director Mr. Matitiahu Shem Tov
Sector Technology
Industry Information Technology Services
Full time employees 12000
Full time employees 12000

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​